• Belgian Biotech gets a €40M Boost to Keep up in the CAR-T Race
    Belgian biotech Celyad has raised substantial funding on Euronext Paris and the NASDAQ to support its CAR-T cell therapy, which can be applied to both solid and blood tumors. CYAD-01, its most advanced drug candidate, is currently in Phase I trials. The funding could help Celyad keep up with other CAR-T developers.

  • Swedish Biotech Partners With Novo Nordisk to Advance Stem Cell Therapies for Diabetes
    BioLamina, based in Stockholm, is collaborating with the world-leader in diabetes treatment Novo Nordisk to develop stem cell therapies that use BioLamina’s protein cell culture matrices. BioLamina’s technology could enhance Novo Nordisk’s stem cell therapies effectiveness in treating diabetes.

  • Even Old Brains Can Make New Neurons, Study Finds
    In research published today in the journal Cell Stem Cell, scientists at Columbia University Vagelos College of Physicians and Surgeons present the most definitive evidence to date that the human brain makes new neurons throughout life.

  • Breakthrough in understanding of how red blood cells develop
    By taking a deep dive into the molecular underpinnings of Diamond-Blackfan anemia, scientists have made a new discovery about what drives the development of mature red blood cells from the earliest form of blood cells, called hematopoietic (blood-forming) stem cells.

  • New Method Could Improve Longevity and Lessen Wear of Artificial Hips
    Mechanical engineering researchers have developed a method that could extend the life of an artificial hip by adding an array of microscopic indentations that increase the thickness of a lubricating film on its surface.

 

 

Vice-presidency News
Test implementation standards in the section of laboratory services will be presented to users
The manager of strategic technologies laboratory network stated: in the laboratory services section, test implementation standards and search of tests related to products will be presented to users.
 13:30 - 05/05/2018 - Comments : 0More >>
30 percent growth in the number of specialized workgroups of the laboratory network
Manager of the strategic technologies laboratory network announced the 30% growth in the number of members of the specialized workgroups of the laboratory network.
 11:10 - 22/04/2018 - Comments : 0More >>
World News
Belgian Biotech gets a €40M Boost to Keep up in the CAR-T Race
Belgian biotech Celyad has raised substantial funding on Euronext Paris and the NASDAQ to support its CAR-T cell therapy, which can be applied to both solid and blood tumors. CYAD-01, its most advanced drug candidate, is currently in Phase I trials. The funding could help Celyad keep up with other CAR-T developers.
 11:26 - 23/05/2018 - Comments : 0More >>
Swedish Biotech Partners With Novo Nordisk to Advance Stem Cell Therapies for Diabetes
BioLamina, based in Stockholm, is collaborating with the world-leader in diabetes treatment Novo Nordisk to develop stem cell therapies that use BioLamina’s protein cell culture matrices. BioLamina’s technology could enhance Novo Nordisk’s stem cell therapies effectiveness in treating diabetes.
 08:24 - 23/05/2018 - Comments : 0More >>
Council News
The 3rd National Festival and International Congress on Stem Cells and Regenerative Medicine Published in Nature Events Directory
Nowadays, with the increasing knowledge of physiological and pathologic cellular processes as well as extensive research on signaling pathways, interaction of cells through extracellular vesicles, development of organoids and their application in disease modeling and drug screening and also the advent of new technologies in cellular engineering and genetic manipulation, we have witnessed dramatic changes in the field of regenerative medicine and particularly cell therapy.
 13:11 - 16/05/2018 - Comments : 0More >>
The 3rd National Festival and International Congress on Stem Cells and Regenerative Medicine
Considerable advances in Stem Cells and Regenerative Medicine during the past decade, has created much hope for the treatment of chronic and incurable illnesses, such as various cancers, genetic illnesses, illnesses due to old age, and deterioration of tissues and organs
 12:02 - 22/04/2018 - Comments : 0More >>
National News
The Leader picks “Support for Iranian Products” as New Year’s motto:
All must work to realize this year’s motto
In a message marking the arrival of the Solar calendar year of 1397 (beginning March 21, 2018), Leader of the Islamic Revolution Ayatollah Seyyed Ali Khamenei congratulated all Iranian compatriots, particularly the respectable families of martyrs and the war-wounded as well as promising youths and teenagers, who are the driving force behind the country’s scientific movement.
 11:45 - 07/04/2018 - Comments : 0More >>
President Hassan Rouhani:
Great Steps Have Been Taken in Various Fields During Last Year
President Rouhani described year 1396 as the year of success for the great Iranian nation in various fields despite the wish of the enemies and said: “The unity among the Iranian nation has surprised all enemies and they admitted to the greatness of our people”.
 11:38 - 07/04/2018 - Comments : 0More >>